Molecular Mechanisms Involved in Craniosynostosis

Area of Science:

• Craniofacial Surgery
• Medical Genetics
• Pediatric Health

Background:

• Craniosynostosis is the early fusion of cranial sutures, leading to craniofacial abnormalities, affecting 1 in 2,500 births globally.
• It occurs sporadically (non-syndromic) in 85% of cases and as part of syndromes (syndromic) in 15%, with syndromic cases exhibiting more severe symptoms.
• Common syndromic forms include Pfeiffer, Apert, Crouzon, Jackson-Weiss, Muenke, and Boston type MSX2-related syndromes.

Purpose of the Study:

• To review the primary therapeutic approaches for craniosynostosis.
• To highlight the genetic basis and common syndromes associated with craniosynostosis.
• To provide an overview of craniofacial abnormalities resulting from premature suture fusion.

Main Methods:

• This review discusses surgical interventions as the main therapeutic approach for craniosynostosis.
• It examines the genetic mutations, including FGFR1, FGFR2, FGFR3, TWIST1, and MSX2, involved in cranial bone morphogenesis.
• The review categorizes craniosynostosis into syndromic and non-syndromic forms based on clinical presentation.

Main Results:

• Craniosynostosis necessitates surgical treatment, with the specific approach determined by the condition's severity.
• Genetic factors play a crucial role, with mutations in specific genes influencing the development of craniofacial abnormalities.
• Syndromic craniosynostosis generally presents with more complex and severe symptoms than non-syndromic cases.

Conclusions:

• Surgical management is the cornerstone of treating craniosynostosis.
• Understanding the genetic underpinnings and syndromic associations is vital for effective patient care.
• Treatment strategies are individualized based on the specific type and severity of craniosynostosis.